Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

被引:39
作者
Raphael, Eva [1 ,2 ,4 ]
Glymour, M. Maria [2 ]
Chambers, Henry F. [3 ,5 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Zuckerberg San Francisco Gen Hosp, 995 Potrero Ave,Ward 83, San Francisco, CA 94110 USA
[5] Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA
基金
美国国家卫生研究院;
关键词
Extended-spectrum beta-lactamase; Escherichia coli; Antimicrobial resistance; Bacteriuria; Risk factors; URINARY-TRACT-INFECTIONS; RISK-FACTORS; RESISTANCE PATTERNS; ENTEROBACTERIACEAE; NITROFURANTOIN; ACQUISITION; FOSFOMYCIN;
D O I
10.1186/s13756-021-00983-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The prevalence of infections caused by extended-spectrum beta-lactamase producing Escherichia coli (ESBL-E. coli) is increasing worldwide, but the setting in which this increase is occurring is not well defined. We compared trends and risk factors for ESBL-E. coli bacteriuria in community vs healthcare settings. Methods We collected electronic health record data on all patients with E. coli isolated from urine cultures in a safety-net public healthcare system from January 2014 to March 2020. All analyses were stratified by healthcare-onset/associated (bacteriuria diagnosed > 48 h after hospital admission or in an individual hospitalized in the past 90 days or in a skilled nursing facility resident, N = 1277) or community-onset bacteriuria (bacteriuria diagnosed < 48 h after hospital admission or in an individual seen in outpatient clinical settings without a hospitalization in the past 90 days, N = 7751). We estimated marginal trends from logistic regressions to evaluate annual change in prevalence of ESBL-E. coli bacteriuria among all bacteriuria. We evaluated risk factors using logistic regression models. Results ESBL-E. coli prevalence increased in both community-onset (0.91% per year, 95% CI 0.56%, 1.26%) and healthcare-onset/associated (2.31% per year, CI 1.01%, 3.62%) bacteriuria. In multivariate analyses, age > 65 (RR 1.88, CI 1.17, 3.05), male gender (RR 2.12, CI 1.65, 2.73), and Latinx race/ethnicity (RR 1.52, CI 0.99, 2.33) were associated with community-onset ESBL-E. coli. Only male gender (RR 1.53, CI 1.03, 2.26) was associated with healthcare-onset/associated ESBL-E. coli. Conclusions ESBL-E. coli bacteriuria frequency increased at a faster rate in healthcare-associated settings than in the community between 2014 and 2020. Male gender was associated with ESBL-E. coli bacteriuria in both settings, but additional risks-age > 65 and Latinx race/ethnicity-were observed only in the community.
引用
收藏
页数:13
相关论文
共 37 条
[1]   Antimicrobial susceptibility profiles of bacteria causing urinary tract infections in Mexico: Single-centre experience with 10 years of results [J].
Alejandro Lagunas-Rangel, Francisco .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 14 :90-94
[2]  
[Anonymous], 2013, AGING HLTH, DOI DOI 10.2217/AHE.13.38
[3]   Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections [J].
Azap, Oe K. ;
Arslan, H. ;
Serefhanoglu, K. ;
Colakoglu, S. ;
Erdogan, H. ;
Timurkaynak, F. ;
Senger, S. S. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) :147-151
[4]   High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden [J].
Balkhed, Ase Ostholm ;
Tarnberg, Maria ;
Monstein, Hans-Jurg ;
Hallgren, Anita ;
Hanberger, Hakan ;
Nilsson, Lennart E. .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (04) :271-278
[5]   Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines [J].
Bours, P. H. A. ;
Polak, R. ;
Hoepelman, A. I. M. ;
Delgado, E. ;
Jarquin, A. ;
Matute, A. J. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (09) :E770-E774
[6]   Risk Factors Associated with Community-Acquired Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli: a Systematic Review [J].
Butcher, Cheyenne R. ;
Rubin, Julia ;
Mussio, Kaitlyn ;
Riley, Lee W. .
CURRENT EPIDEMIOLOGY REPORTS, 2019, 6 (03) :300-309
[7]   Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases [J].
Calbo, E ;
Romaní, V ;
Xercavins, M ;
Gómez, L ;
Vidal, CG ;
Quintana, S ;
Vila, J ;
Garau, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :780-783
[8]  
Centers for Disease Control and Prevention, 2019, ANTIBIOTIC RESISTANC
[9]   Hospitalization-Associated Disability in Adults Admitted to a Safety-Net Hospital [J].
Chodos, Anna H. ;
Kushel, Margot B. ;
Greysen, S. Ryan ;
Guzman, David ;
Kessell, Eric R. ;
Sarkar, Urmimala ;
Goldman, L. Elizabeth ;
Critchfield, Jeffrey M. ;
Pierluissi, Edgar .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 (12) :1765-1772
[10]  
CLSI, 2016, Performance standards for antimicrobial susceptibility testing, V26th